Wells Fargo
WHWK

Wells Fargo’s Whitehawk Therapeutics WHWK Stock Holding History

Wells Fargo’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$124K Buy
+27,174
New +$113K ﹤0.01% 5444
2025
Q2 		– Sell
-33
Closed -$59 – 7442
2025
Q1 		$59 Sell
33
-567
-95% -$1.48K ﹤0.01% 6428
2024
Q4 		$1.89K Sell
600
-2,222
-79% -$5.03K ﹤0.01% 6195
2024
Q3 		$5.81K Sell
2,822
-200
-7% -$323 ﹤0.01% 5898
2024
Q2 		$4.41K Sell
3,022
-6,769
-69% -$12.5K ﹤0.01% 5892
2024
Q1 		$22.9K Buy
9,791
+737
+8% +$1.42K ﹤0.01% 5543
2023
Q4 		$18.3K Buy
9,054
+723
+9% +$3.03K ﹤0.01% 5668
2023
Q3 		$40.3K Sell
8,331
-1,983
-19% -$11.5K ﹤0.01% 5293
2023
Q2 		$70.5K Buy
10,314
+5,592
+118% +$43.5K ﹤0.01% 5242
2023
Q1 		$34.2K Buy
4,722
+3,156
+202% +$33.7K ﹤0.01% 5376
2022
Q4 		$20.1K Sell
1,566
-158
-9% -$2.06K ﹤0.01% 5259
2022
Q3 		$25K Sell
1,724
-365
-17% -$4.8K ﹤0.01% 5297
2022
Q2 		$26K Buy
2,089
+997
+91% +$14.8K ﹤0.01% 5326
2022
Q1 		$18K Buy
1,092
+298
+38% +$5.71K ﹤0.01% 6058
2021
Q4 		$19K Buy
794
+714
+893% +$17.9K ﹤0.01% 6350
2021
Q3 		$2K Sell
80
-1
-1% -$30 ﹤0.01% 6603
2021
Q2 		$2K Hold
81
– – ﹤0.01% 6571
2021
Q1 		$1K Hold
81
– – ﹤0.01% 6783
2020
Q4 		$1K Buy
81
+33
+69% +$706 ﹤0.01% 6392
2020
Q3 		$1K Buy
48
+2
+4% +$42 ﹤0.01% 6244
2020
Q2 		$1K Buy
46
+36
+360% +$471 ﹤0.01% 6199
2020
Q1 		$0 Buy
+10
New +$92 ﹤0.01% 6941

Other funds holding WHWK

YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wells Fargo's WHWK Position: Q2 2026 in Review

Wells Fargo opened a new position in Whitehawk Therapeutics (WHWK) in Q2 2026: 27,174 shares worth $124K. The stake represents ﹤0.01% of the portfolio and ranks #5444 among its holdings. This is a return to the name: Wells Fargo previously reported a position in WHWK as recently as Q1 2025.

Wells Fargo first reported a position in WHWK in Q1 2020 and has held it in 22 quarters since. 78 funds tracked by Wall St. Rank hold WHWK as of Q2 2026.

  • Wells Fargo held 27,174 shares of Whitehawk Therapeutics worth $124K as of Q2 2026.
  • Whitehawk Therapeutics was a new Wells Fargo position in Q2 2026.
  • Whitehawk Therapeutics made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #5444 holding.
  • Wells Fargo first reported a position in Whitehawk Therapeutics in Q1 2020 and has held it in 22 quarters since.
  • 78 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.